Health condition
Kaposi sarcoma non-HIV
Kaposi sarcoma occurs outside HIV in three settings - classic disease of older Mediterranean and Eastern European men, transplant-related disease, and endemic African forms; all are driven by HHV-8 and most run an indolent, controllable course.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
All Kaposi sarcoma is driven by human herpesvirus 8 (HHV-8)
-
Classic KS: slow purple-brown plaques on the lower legs of older men
-
Transplant-associated KS often regresses when immunosuppression is switched to an mTOR inhibitor
-
Indolent disease may need only observation or local treatment
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
The classic form progresses over years: violaceous patches and nodules on the feet and lower legs, sometimes with leg swelling, in men of Mediterranean, Middle Eastern or Eastern European heritage whose immune control of HHV-8 has waned with age. It is usually more of a chronic condition than a lethal one. Transplant recipients develop a brisker version, a direct consequence of pharmacological immunosuppression.
Diagnosis and treatment routes
An HIV test is part of every new diagnosis, whatever the presumed category. Management is proportionate: observation, radiotherapy or intralesional treatment for limited classic disease; liposomal chemotherapy or, increasingly, immunotherapy for extensive or visceral involvement; and, in transplant patients, conversion of immunosuppression to sirolimus, which can itself induce regression while protecting the graft. Skin surveillance continues lifelong, as new lesions can appear over time. If you are waiting for results or want a second opinion on a proposed plan, a private consultation with a specialist who treats this condition regularly can usually be arranged quickly, and most will review your existing scans, biopsy reports and MDT correspondence.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant oncologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about Kaposi sarcoma non-HIV.
Quick, plain-English answers to what people ask us most.
-
What is non-HIV Kaposi sarcoma?
Non-HIV Kaposi sarcoma is a cancer of the blood vessel lining caused by human herpesvirus 8 (HHV-8) infection, occurring in people without HIV, typically those with weakened immune systems from other causes such as organ transplantation or older age (classic Kaposi sarcoma). It appears as purplish skin lesions and can also affect internal organs.
-
What causes non-HIV Kaposi sarcoma?
It is caused by HHV-8 infection combined with some degree of immune suppression, whether from ageing, organ transplant medication, or other immune-weakening conditions. The virus drives abnormal growth of blood vessel cells, forming the characteristic lesions.
-
What are the symptoms of non-HIV Kaposi sarcoma?
Symptoms typically include purple, red or brown patches, plaques or nodules on the skin, often on the legs, and sometimes swelling from lymphatic involvement. In more extensive disease, lesions can also occur in the mouth, gut or lungs.
-
Is non-HIV Kaposi sarcoma dangerous?
Classic Kaposi sarcoma in elderly patients often progresses slowly and may be manageable for years, but forms linked to significant immune suppression, such as after transplant, can be more aggressive. Internal organ involvement is more concerning and needs prompt treatment.
-
Is non-HIV Kaposi sarcoma genetic?
It is not a hereditary condition; it depends on infection with HHV-8 combined with reduced immune surveillance rather than inherited genetic mutations. Certain populations have higher rates of HHV-8 infection, which influences regional prevalence.
-
Can non-HIV Kaposi sarcoma be treated?
Yes, treatment options include reducing immunosuppressive medication where possible (in transplant patients), local therapies such as surgery, cryotherapy or radiotherapy for limited disease, and chemotherapy for widespread disease. Many cases respond well to treatment, especially when caught early.
-
How is non-HIV Kaposi sarcoma treated?
Treatment is tailored to disease extent and the underlying cause of immune suppression: adjusting transplant medications, local skin-directed treatments for limited lesions, or systemic chemotherapy for more extensive or internal disease. Close monitoring after treatment is important given the risk of recurrence.
-
How long does treatment for non-HIV Kaposi sarcoma take?
Response times vary with the treatment approach and extent of disease, ranging from weeks for localised therapy to several months for systemic treatment of widespread disease. Your oncologist will give a personalised timeline based on your specific case.
-
Non-HIV Kaposi sarcoma vs HIV-associated Kaposi sarcoma — what's the difference?
Both are caused by HHV-8, but HIV-associated Kaposi sarcoma tends to be more aggressive and widespread due to more severe immune suppression, while classic (non-HIV) Kaposi sarcoma in older adults often progresses more slowly. Treatment approaches differ accordingly, with HIV treatment itself often improving HIV-associated disease.
-
When should I see a doctor about Kaposi sarcoma, and how quickly can I be seen privately?
Any unexplained purple or dark skin lesions, particularly in someone who is immunosuppressed or elderly, should be assessed by a dermatologist or oncologist promptly. Private specialist consultations can typically be arranged within about two weeks, much sooner than standard NHS referral routes.